Skip to main content

Dave Muoio

By Dave Muoio | 04:19 pm | May 26, 2020
The digital respiratory health company says this deal and clearance now give it access to 90% of the U.S. asthma and COPD market.
By Dave Muoio | 01:21 pm | May 26, 2020
insitro unveiled a $143 million Series B round on the same day that fellow machine learning company Exscientia highlighted its own $60 million Series C raise.
By Dave Muoio | 03:21 pm | May 22, 2020
The in-app study collects wearable data and asks participants about their recent symptom history.
By Dave Muoio | 10:57 am | May 22, 2020
Two recent programs deploying telemedicine in Zimbabwe and Ghana highlight common hurdles programs that deliver these technologies to underserved areas will likely encounter.
By Dave Muoio | 12:51 pm | May 21, 2020
naviHealth will continue to work with its clients and members as a stand-alone entity aligned with OptumHealth.
By Dave Muoio | 04:48 pm | May 20, 2020
Opt-in "Exposure Notifications" are included in new operating system updates on both companies' platforms and available now to worldwide public health agencies.
By Dave Muoio | 12:31 pm | May 20, 2020
The young service says that it has been seeing a marked increase in users over the past few months.
By Dave Muoio | 04:57 pm | May 19, 2020
Alongside the purchase and service launch, the digital health company also shared news of a $57 million investment from Perceptive Advisors.
By Dave Muoio | 12:40 pm | May 19, 2020
The consumer-facing digital platform for health testing was forced to pump the brakes on a similar offering roughly two months ago.
By Dave Muoio | 05:16 pm | May 14, 2020
Also: Intel, UPenn and others employ AI for brain tumor identification; DrChrono integrates EHRsynergy's documentation tool.